Safety and outcomes of bronchoscopic lung volume reduction with endobronchial valves under moderate sedation.

ABSTRACT:

Background

Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality worldwide. Bronchoscopic lung volume reduction (BLVR) using endobronchial valves (EBV) offers a minimally invasive treatment for severe emphysema. Traditionally performed under general anesthesia (GA), this study evaluates whether BLVR performed under moderate sedation (MS) potentially has less adverse events as compared to ones done under GA.

Methods

This retrospective analysis included 65 patients who underwent BLVR with EBV placement at the University of Florida between January 2020 and June 2022. All procedures were performed under MS. Primary outcomes assessed included the incidence of pneumothorax (PTX), while secondary outcomes comprised valve removal rates, need

SUBMITTER: Reinoso JL 

PROVIDER: S-EPMC11898378 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature